Vice President, Global Regulatory Affairs
Nach Davé likes to think “beyond the pill,” combining innovation, technology, and global expertise to help customers achieve their product development goals. “We’re most effective as a CRO when we advance new methodologies and regulatory strategies that enable our customers to bring high-quality therapies to market more quickly,” he says.
Mr. Davé oversees Premier Research’s regulatory affairs service offerings across its broad range of therapeutic focus areas, bringing to his position more than 20 years of experience in the pharmaceutical and contract research industries. He previously served the company as Director of Regulatory Affairs and rejoined Premier Research after two years as Senior Director of Regulatory Affairs at PRA Health Sciences.
“I chose Premier Research because the company is in this business for the right reasons,” Mr. Davé says. “There’s a very evident passion for clinical research and a commitment to improve lives, provide hope, and create a healthier world.”
He also led clinical and regulatory affairs at Maxx Orthopedics, a developer of orthopedic medical devices, and has held roles in clinical operations, business development, strategic consulting, and medical affairs at companies such as Merck, Bristol-Myers Squibb, Aventis Pharmaceuticals, and Mitsubishi Pharma America.
Mr. Davé holds a master’s degree in drug regulatory affairs from Long Island University and a bachelor’s degree in pharmacy from the Philadelphia College of Pharmacy and Sciences. He is a registered pharmacist in the state of New Jersey.